Ceftazidime (Sagent Pharmaceuticals)


Welcome to the PulseAid listing for the Ceftazidime drug offered from Sagent Pharmaceuticals. This Cephalosporin Antibacterial [EPC],Cephalosporins [Chemical/Ingredient] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: Sagent Pharmaceuticals
NON-PROPRIETARY NAME: ceftazidime
SUBSTANCE NAME: CEFTAZIDIME
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS: Cephalosporin Antibacterial [EPC],Cephalosporins [Chemical/Ingredient]
ROUTE: INTRAMUSCULAR; INTRAVENOUS
DOSAGE FORM: INJECTION, POWDER, FOR SOLUTION
MARKETING CATEGORY NAME: ANDA
START MARKETING DATE: 2015-07-01
END MARKETING DATE: 0000-00-00


Ceftazidime HUMAN PRESCRIPTION DRUG Details:

Item DescriptionCeftazidime from Sagent Pharmaceuticals
LABELER NAME: Sagent Pharmaceuticals
DEA SCHEDULE:
ACTIVE STRENGTH: 1(g/1)
START MARKETING DATE: 2015-07-01
END MARKETING DATE: 0000-00-00
PRODUCT ID: 25021-127_eda01cb1-0b83-4275-83c9-716401bafc48
PRODUCT NDC: 25021-127
APPLICATION NUMBER: ANDA062640

Other CEFTAZIDIME Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
B. Braun Medical Inc.Ceftazidime and Dextrose
Hospira, Inc.TAZICEF
Sagent PharmaceuticalsCeftazidime
Sandoz IncCeftazidime
WG Critical Care, LLCCeftazidime